MinorEstrogens – natural and semisynthetic×Selective serotonin reuptake inhibitors
Updated · Methodology
Mechanism
CYP3A4 partly metabolises estradiol. Strong and moderate inhibitors of this enzyme, such as azole antifungals, verapamil, macrolides and diltiazem, can raise oestrogen levels (Progynova SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS; estradiol tablets label, US Food and Drug Administration, FDA). Fluoxetine strongly inhibits a different enzyme, CYP2D6 (fluoxetine SmPC, AEMPS). In laboratory studies, ketoconazole inhibited CYP3A4 at least 100 times more strongly than fluoxetine or norfluoxetine. In humans, fluoxetine did not raise the levels of terfenadine, a CYP3A4 substrate. Inhibition of CYP3A4 by fluoxetine is therefore unlikely to be clinically significant (Prozac label, FDA).
Symptoms
The documents describe no symptoms linked to this combination. Each drug keeps its own adverse effects. The most frequent adverse effects of fluoxetine are headache, nausea, insomnia, fatigue and diarrhoea (fluoxetine SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). The adverse effects of estradiol in hormone replacement therapy include uterine or vaginal bleeding and spotting, breast pain, headache, nausea, oedema and depressed mood (Progynova SmPC, AEMPS).
Management
According to the documents, the combination is acceptable, and the doses of fluoxetine and estradiol need no change. No document names the pair, and inhibition of CYP3A4 by fluoxetine is unlikely to be clinically significant (fluoxetine SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS, and Prozac label, US Food and Drug Administration, FDA). The estradiol SmPC gives azole antifungals, verapamil, macrolides, diltiazem and grapefruit juice as examples of strong and moderate CYP3A4 inhibitors that can raise oestrogen levels. Fluoxetine is not among them (Progynova SmPC, AEMPS). Fluoxetine and its metabolite norfluoxetine are eliminated slowly and remain in the body for 5–6 weeks after fluoxetine is stopped. Take this into account when assessing any interaction (fluoxetine SmPC, AEMPS).
Your whole list in one report
Up to 15 drugs: every pair in one table and a PDF report. Your first report is free: we only ask for your email
Add more drugsMedicine list: everything you take in one place →
Sources
- FDA: Prozac (fluoxetine) prescribing information (2026)– FDA label, DailyMed setid c88f33ed-6dfb-4c5e-bc01-d8e36dd97299, version 59, revised 01/2026, section 7.7 Drugs Metabolized by CYP2D6
- AEMPS: Ficha técnica: Fluoxetina, Fluoxetina Cinfa 20 mg (nº registro 63499) (2026)– AEMPS, CIMA, nº registro 63499 (Fluoxetina Cinfa 20 mg cápsulas duras EFG), revisión 10/2026, secciones 4.3, 4.4 y 4.5
- AEMPS: Ficha técnica: Estradiol (nº registro 47814), sección 4.5 (2026)– AEMPS, CIMA, nº registro 47814, revisión 02/2026, sección 4.5
- FDA: Estradiol tablets, Teva (estradiol) prescribing information (2024)– FDA, DailyMed setid c4936878-1643-4e7f-9b0d-e4957935aef2 (Teva Pharmaceuticals USA), revisión 02/2024 (versión 16), CLINICAL PHARMACOLOGY (Drug Interactions), PRECAUTIONS (Fluid retention, Exacerbation of other conditions)